美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tao Synergies Inc.

8.08

-0.2700-3.23%

成交量：34.22萬

成交額：273.07萬

市值：1,122.97萬

市盈率：-0.82

高：8.94

開：7.91

低：7.51

收：8.35

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Tao Synergies Inc.

交易所：

NASDAQ

成立時間：

2012

員工人數：

4

公司地址：

1185 Avenue of the Americas,3rd Floor,New York,New York,United States

官網：

http://www.synaptogen.com

郵編：

10036

電話：

傳真：

- -

簡介：

Synaptogenix, Inc.於2012年10月31日在特拉華州註冊成立。該公司是一家生物製藥公司，擁有處於臨床前和臨床開發階段的候選產品。該公司主要專註於開發基於一種名為Bryostatin-1的候選藥物的產品平台，該藥物由從海洋無脊椎動物生物體中分離出來的天然產物（bryostatin）合成，用於治療阿爾茨海默病（“AD”），該藥物正處於臨床測試階段。

董事

名稱

職位

Joshua Silverman

Executive Chairman of the Board

William S. Singer

Vice Chairman of the Board

Alan J. Tuchmam

Chief Medical Officer,Director

Bruce T. Bernstein

Independent Director

Jonathan L. Schechter

Independent Director

股東

名稱

職位

Robert Weinstein

Chief Financial Officer, Secretary and Executive Vice President

Alan J. Tuchmam

Chief Medical Officer,Director

Joshua Silverman

Executive Chairman of the Board

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TAOX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAOX\",,,,,undefined,":{"symbol":"TAOX","market":"US","secType":"STK","nameCN":"Tao Synergies Inc.","latestPrice":8.08,"timestamp":1751486400000,"preClose":8.35,"halted":0,"volume":342231,"delay":0,"floatShares":1380701,"shares":1389815,"eps":-9.900128,"marketStatus":"盤前交易","change":-0.27,"latestTime":"07-03 06:06:30 EDT","open":7.91,"high":8.94,"low":7.51,"amount":2730686.6452095,"amplitude":0.171257,"askPrice":8.15,"askSize":400,"bidPrice":7.32,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-9.900128,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1751549400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":8.08,"postHourTrading":{"tag":"盘后","latestPrice":8.31,"preClose":8.08,"latestTime":"19:59 EDT","volume":4167,"amount":34387.04,"timestamp":1751500778920},"volumeRatio":0.5035507261898396},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAOX\",,,,,undefined,":{"symbol":"TAOX","floatShares":1380701,"roa":"-17.29%","roe":"-83.05%","lyrEps":-10.990077,"volumeRatio":0.5035507261898396,"shares":1389815,"dividePrice":0,"high":8.94,"amplitude":0.171257,"preClose":8.35,"low":7.51,"week52Low":1.84,"pbRate":"2.17","week52High":8.94,"institutionHeld":0,"latestPrice":8.08,"committee":-0.6,"eps":-9.900128,"divideRate":0,"volume":342231,"delay":0,"ttmEps":-9.900128,"open":7.91,"prevYearClose":3.47,"prevWeekClose":6.045,"prevMonthClose":7.85,"prevQuarterClose":7.85,"fiveDayClose":3.77,"twentyDayClose":2.6,"sixtyDayClose":2.0201},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":268943522,"yearFounded":2012,"employeeNum":4,"address":"1185 Avenue of the Americas,3rd Floor,New York,New York,United States","zipCode":"10036","officePhone":"973 242 0005"},"stockCompanyDetail":{"websiteUrl":"http://www.synaptogen.com","stockEarnings":[{"period":"1week","weight":1.0875},{"period":"1month","weight":2.3201},{"period":"3month","weight":2.5232},{"period":"6month","weight":1.3588},{"period":"1year","weight":1.012},{"period":"ytd","weight":1.4063}],"compareEarnings":[{"period":"1week","weight":0.0179},{"period":"1month","weight":0.0479},{"period":"3month","weight":0.0941},{"period":"6month","weight":0.0565},{"period":"1year","weight":0.1326},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Synaptogenix, Inc.於2012年10月31日在特拉華州註冊成立。該公司是一家生物製藥公司，擁有處於臨床前和臨床開發階段的候選產品。該公司主要專註於開發基於一種名為Bryostatin-1的候選藥物的產品平台，該藥物由從海洋無脊椎動物生物體中分離出來的天然產物（bryostatin）合成，用於治療阿爾茨海默病（“AD”），該藥物正處於臨床測試階段。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.127459},{"month":2,"riseRate":0.4,"avgChangeRate":0.126015},{"month":3,"riseRate":0.2,"avgChangeRate":-0.086787},{"month":4,"riseRate":0.8,"avgChangeRate":-0.019924},{"month":5,"riseRate":0.4,"avgChangeRate":-0.038398},{"month":6,"riseRate":0.6,"avgChangeRate":0.501694},{"month":7,"riseRate":0.4,"avgChangeRate":-0.025825},{"month":8,"riseRate":0.25,"avgChangeRate":-0.02833},{"month":9,"riseRate":0.25,"avgChangeRate":-0.037469},{"month":10,"riseRate":0.5,"avgChangeRate":-0.07233},{"month":11,"riseRate":0,"avgChangeRate":-0.095254},{"month":12,"riseRate":0.5,"avgChangeRate":-0.159791}],"exchange":"NASDAQ","name":"Tao Synergies Inc.","nameEN":"Tao Synergies Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TAOX\",market:\"US\",,,undefined,":{"directors":[{"name":"Joshua Silverman","position":"Executive Chairman of the Board"},{"name":"William S. Singer","position":"Vice Chairman of the Board"},{"name":"Alan J. Tuchmam","position":"Chief Medical Officer,Director"},{"name":"Bruce T. Bernstein","position":"Independent Director"},{"name":"Jonathan L. Schechter","position":"Independent Director"}],"executives":[{"name":"Robert Weinstein","position":"Chief Financial Officer, Secretary and Executive Vice President"},{"name":"Alan J. Tuchmam","position":"Chief Medical Officer,Director"},{"name":"Joshua Silverman","position":"Executive Chairman of the Board"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAOX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAOX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAOX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAOX","date":"2025-07-02","current":-0.953047,"percent":1,"low":-0.953047,"twenty":-0.953047,"median":-0.953047,"eighty":-0.953047,"high":-0.953047,"avg":-0.953047,"sd":0,"marketCap":11604955},"quantilePoints":[{"date":"2025-07-02","current":-0.953047,"twenty":-0.953047,"median":-0.953047,"eighty":-0.953047,"marketCap":11604955}],"updateTime":1751536963894}}}